Covered recipient · General Payments record
SYLVA GARAGULAKIAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$7,255.26
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,712.52 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $366.29 | 13 |
| Phathom Pharmaceuticals, Inc. | $281.56 | 3 |
| Amgen Inc. | $264.26 | 10 |
| Lilly USA, LLC | $187.43 | 9 |
| PFIZER INC. | $168.13 | 6 |
| Abbott Laboratories | $158.21 | 3 |
| Astellas Pharma US Inc | $132.54 | 2 |
| DEXCOM, INC. | $57.81 | 3 |
| Merck Sharp & Dohme Corporation | $48.69 | 2 |
| ABBVIE INC. | $24.72 | 1 |
| GlaxoSmithKline, LLC. | $22.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.02 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124904454 | CMS |
| Abbott Laboratories | $114.72 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124904456 | CMS |
| Abbott Laboratories | $19.47 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124904458 | CMS |
| ABBVIE INC. | $24.72 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107147228 | CMS |
| Amgen Inc. | $16.07 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559161 | CMS |
| Amgen Inc. | $16.11 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559163 | CMS |
| Amgen Inc. | $121.83 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559177 | CMS |
| Amgen Inc. | $17.72 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559165 | CMS |
| Amgen Inc. | $17.22 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559167 | CMS |
| Amgen Inc. | $14.71 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117257147 | CMS |
| Amgen Inc. | $15.83 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559169 | CMS |
| Amgen Inc. | $9.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559171 | CMS |
| Amgen Inc. | $16.43 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559173 | CMS |
| Amgen Inc. | $18.99 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117559175 | CMS |
| Astellas Pharma US Inc | $107.44 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139523220 | CMS |
| Astellas Pharma US Inc | $25.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139510307 | CMS |
| Dexcom, Inc. | $20.84 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388549 | CMS |
| Dexcom, Inc. | $15.37 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388551 | CMS |
| Dexcom, Inc. | $21.60 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388553 | CMS |
| GlaxoSmithKline, LLC. | $22.88 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116461150 | CMS |
| Lilly USA, LLC | $32.60 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135893656 | CMS |
| Lilly USA, LLC | $30.51 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957797 | CMS |
| Lilly USA, LLC | $34.46 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135967516 | CMS |
| Lilly USA, LLC | $32.24 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135869802 | CMS |
| Lilly USA, LLC | $9.85 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135893660 | CMS |
| Lilly USA, LLC | $30.44 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957799 | CMS |
| Lilly USA, LLC | $4.31 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135893664 | CMS |
| Lilly USA, LLC | $5.96 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135961799 | CMS |
| Lilly USA, LLC | $7.06 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135961801 | CMS |
| Merck Sharp & Dohme LLC | $19.80 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141853595 | CMS |
| Merck Sharp & Dohme LLC | $28.89 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141977362 | CMS |
| Novo Nordisk Inc | $16.42 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100521815 | CMS |
| Novo Nordisk Inc | $1.72 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100567472 | CMS |
| Novo Nordisk Inc | $1.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550746 | CMS |
| Novo Nordisk Inc | $4.14 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100532401 | CMS |
| Novo Nordisk Inc | $22.41 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100396988 | CMS |
| Novo Nordisk Inc | $19.54 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100584150 | CMS |
| Novo Nordisk Inc | $13.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100393440 | CMS |
| Novo Nordisk Inc | $4.86 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100286154 | CMS |
| Novo Nordisk Inc | $121.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100266590 | CMS |
| Novo Nordisk Inc | $8.18 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520433 | CMS |
| Novo Nordisk Inc | $1.91 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100511113 | CMS |
| Novo Nordisk Inc | $120.85 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100555863 | CMS |
| Novo Nordisk Inc | $29.06 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100551090 | CMS |
| PFIZER INC. | $21.53 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131138158 | CMS |
| PFIZER INC. | $18.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131205992 | CMS |
| PFIZER INC. | $25.60 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131760552 | CMS |
| PFIZER INC. | $23.01 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131858117 | CMS |
| PFIZER INC. | $60.53 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132134713 | CMS |
| PFIZER INC. | $19.03 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131211114 | CMS |
| Phathom Pharmaceuticals, Inc. | $126.88 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151167194 | CMS |
| Phathom Pharmaceuticals, Inc. | $125.00 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151167196 | CMS |
| Phathom Pharmaceuticals, Inc. | $29.68 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151167198 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.